Tokyo, Nov. 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059719) titled 'Effects of Test Beverage Consumption on Health Benefits' on Nov. 11.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo

Primary Sponsor: Institute - Mizkan Holdings Co., Ltd.

Condition: Condition - Healthy person Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To assess the health-promoting effects of four-week test beverage consumption. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Test beverage consumption twice daily for four weeks Interventions/Control_2 - Placebo beverage consumption twice daily for four weeks

Eligibility: Age-lower limit - 20 years-old

Gender - Male and Female Key inclusion criteria - 1. Individuals aged 20 to 65 years who do not meet the exclusion criteria. 2. Individuals who understand the contents of the informed consent explanation and can provide written consent voluntarily. 3. Individuals who are not continuously consuming beverages containing the main ingredients of the test beverage. Key exclusion criteria - 1. Individuals with a history of serious diseases of the brain, nervous system, cardiovascular system, or other severe disorders, or those currently under treatment (including individuals taking prescribed medications). 2. Individuals with a history of seizures (such as loss of consciousness, coma, or convulsions) due to neurological disorders. 3. Individuals who have difficulty performing essential evaluation items in this study due to hearing or visual impairments. 4. Individuals who are currently pregnant or breastfeeding. 5. Individuals who are currently participating in another clinical trial, or who have participated in another clinical trial within two months prior to obtaining consent. 6. Individuals judged as inappropriate for participation by the principal investigator. Target Size - 120

Recruitment Status: Recruitment status - No longer recruiting Date of protocol fixation - 2024 Year 10 Month 25 Day Date of IRB - 2024 Year 11 Month 12 Day Anticipated trial start date - 2024 Year 12 Month 15 Day Last follow-up date - 2025 Year 02 Month 25 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068268

Disclaimer: Curated by HT Syndication.